Title |
Effect of Age on Stroke Prevention Therapy in Patients With Atrial Fibrillation
|
---|---|
Published in |
Stroke, January 2009
|
DOI | 10.1161/strokeaha.108.526988 |
Pubmed ID | |
Authors |
Carl van Walraven, Robert G. Hart, Stuart Connolly, Peter C. Austin, Jonathan Mant, F D. Richard Hobbs, Peter J. Koudstaal, Palle Petersen, Francisco Perez-Gomez, J Andre Knottnerus, Beppie Boode, Michael D. Ezekowitz, Daniel E. Singer |
Abstract |
Stroke risk increases with age in patients who have nonvalvular atrial fibrillation. It is uncertain whether the efficacy of stroke prevention therapies in atrial fibrillation changes as patients age. The objective of this study was to determine the effect of age on the relative efficacy of oral anticoagulants (OAC) and antiplatelet (AP) therapy (including acetylsalicylic acid and triflusal) on ischemic stroke, serious bleeding, and vascular events in patients with atrial fibrillation. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Canada | 4 | 2% |
United States | 2 | 1% |
Netherlands | 1 | <1% |
Brazil | 1 | <1% |
United Kingdom | 1 | <1% |
Colombia | 1 | <1% |
Spain | 1 | <1% |
Denmark | 1 | <1% |
Unknown | 185 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 27 | 14% |
Student > Master | 23 | 12% |
Student > Postgraduate | 20 | 10% |
Student > Ph. D. Student | 19 | 10% |
Student > Bachelor | 18 | 9% |
Other | 56 | 28% |
Unknown | 34 | 17% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 108 | 55% |
Pharmacology, Toxicology and Pharmaceutical Science | 11 | 6% |
Agricultural and Biological Sciences | 6 | 3% |
Nursing and Health Professions | 6 | 3% |
Economics, Econometrics and Finance | 5 | 3% |
Other | 10 | 5% |
Unknown | 51 | 26% |